InvestorsHub Logo
Followers 4
Posts 930
Boards Moderated 0
Alias Born 06/25/2007

Re: rebmk post# 1341

Tuesday, 11/18/2008 3:15:39 PM

Tuesday, November 18, 2008 3:15:39 PM

Post# of 2070
<<I would think that the probability of non-approval was built into her estimate though.>> I disagree. I think her $11 p.t. was dependent upon FDA approval.

And remember when Bassett was following IDM, she stated she believed that "Junovan" could become a "product platform," with many different applications.